nafronyl has been researched along with Brain Neoplasms in 1 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kempski, O | 1 |
| Chaussy, L | 1 |
| Gross, U | 1 |
| Zimmer, M | 1 |
| Baethmann, A | 1 |
1 other study available for nafronyl and Brain Neoplasms
| Article | Year |
|---|---|
Volume regulation and metabolism of suspended C6 glioma cells: an in vitro model to study cytotoxic brain edema.
Topics: Brain Edema; Brain Neoplasms; Cell Line; Culture Techniques; Energy Metabolism; Flow Cytometry; Glio | 1983 |